Phase Ia study of SYNT001 in healthy volunteers

Trial Profile

Phase Ia study of SYNT001 in healthy volunteers

Phase of Trial: Phase I

Latest Information Update: 01 Nov 2017

At a glance

  • Drugs SYNT 001 (Primary)
  • Indications Autoimmune disorders
  • Focus Adverse reactions
  • Sponsors Syntimmune
  • Most Recent Events

    • 01 Nov 2017 Results presented in an Syntimmune media release.
    • 01 Nov 2017 According to a Syntimmune media release, data from this trial will be presented at the 59th American Society of Hematology (ASH) Annual Meeting.
    • 28 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top